AI assistant
Sending…
REPLIGEN CORP — Director's Dealing 2022
Nov 14, 2022
30826_dirs_2022-11-14_22ab7bd8-65fa-4674-b836-07756bd06b94.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2022-11-11
Reporting Person: Hunt Anthony (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-11-11 | Common Stock | M | 25000 | $33.87 | Acquired | 203265 | Direct |
| 2022-11-11 | Common Stock | S | 25000 | $200.00 | Disposed | 178265 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-11-11 | Stock Option (Right to Buy) | $33.87 | M | 25000 | Acquired | 2028-02-29 | Common Stock (25000) | Direct |
Footnotes
F1: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 14, 2021.
F2: This option is fully vested and exercisable.
More from REPLIGEN CORP
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 27
Annual Report
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23